Based in Spain, Bioherent is a startup. Brouky records 1 investor associated with the company.
Bioherent develops advanced biosensor technology combining silicon photonics and nanomaterials to provide accurate, fast, and accessible in vitro diagnostics for drug allergy detection and research applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.